Florida

ABA / Autism Therapy for Sale — Florida

Through contracts with state agencies, Medicaid, and private insurers, the company has expanded service access and delivered measurable results for vulnerable clients. Their payer mix is nearly 100% Medicaid (via MCOs), but the owner is credentialed with commercial insurances. The company currently serves around 50 pediatric clients weekly in their clinic, homes, and schools.
Asking price
$4,200,000
Annual revenue
$3,000,000
Type
ABA / Autism Therapy
Location
Florida
Listing verified
2026-10-09

Listing broker

This mental health practice is represented by American HealthCare Capital (PRIME exits). Full identity and financials come directly from the listing broker, typically after a confidentiality agreement.

View this listing on the broker's site

More mental health practices for sale in Florida

  • ABA / Autism Therapy

    Florida

    In 2025, revenue was approximately $1.5 million with adjusted EBITDA of approximately $214,000. Top-line revenue increased significantly from 2023 to 2025, reflecting sustained demand for the Company’s services. For 2026, the Company expects revenue to remain near the $1.5 million level as it continues to recruit additional clinical staff.

    Asking price
    $700,000
    Annual revenue
    $1,500,000

    Listed by American HealthCare Capital (PRIME exits)

  • ABA / Autism Therapy

    Florida

    Through contracts with state agencies, Medicaid, and private insurers, the company has expanded service access and delivered measurable results for vulnerable clients. Their payer mix is approximately 38% Medicaid, 30% Private Corporations and Contracts, 16% Medicaid Waiver, and 16% Private Insurance. The company currently serves around 100 clients weekly and 4 major programs, and their client demographic is 54% children and adolescents, 30% private programs, and 16% adults.

    Asking price
    $2,000,000
    Annual revenue
    $1,800,000

    Listed by American HealthCare Capital (PRIME exits)

  • Behavioral Health Practice

    Florida

    Gross revenue was $844,891 in 2023 with an adjusted EBITDA of $57,491. In 2024, they are on pace to surpass $2 million in gross revenue with an adjusted EBITDA of nearly $370,000 based on financials through August. A significant portion of their recent growth is being driven by several insurance companies cutting off a number of local providers in 2024, causing patients to be displaced and seek new providers. Because of this, they feel 2024 revenue may be closer to $2.5 million by the end of the year with an adjusted EBITDA margin above 18%. In 2025, they expect to see continued growth, with a projection to double 2024 revenue at $4 – $5 million and an adjusted EBITDA margin near 20%.

    Asking price
    $3,000,000
    Annual revenue
    $2,500,000

    Listed by American HealthCare Capital (PRIME exits)